HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$3.67
Day range
$3.21 - $3.60
Year range
$3.21 - $16.11
Market cap
4.62M USD
Avg Volume
11.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.17M | -45.17% |
Net income | -2.96M | 46.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.97M | -15.36% |
Total assets | 14.11M | -15.70% |
Total liabilities | 6.63M | 32.61% |
Total equity | 7.48M | — |
Shares outstanding | 1.38M | — |
Price to book | 0.68 | — |
Return on assets | -52.35% | — |
Return on capital | -89.84% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.96M | 46.96% |
Cash from operations | -2.05M | 52.37% |
Cash from investing | 478.00K | -93.63% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -1.57M | -148.92% |
Free cash flow | -62.00K | 98.89% |
About
Founded
1965
Headquarters
Website
Employees
2